Maravai LifeSciences Holdings, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of MRVI for the last quarter is 64.18 M USD, and it's 13.44% lower compared to the previous quarter. The net income of Q1 24 is -12.08 M USD.